Pharmaceutical CDMO Services market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pharmaceutical CDMO Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Pharmaceutical CDMO Services market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services
Segment by Application
Innovative Medicine
Patented Drug
Patent Expired Drug
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Recipharm AB
AMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd
Fareva Group
FAMAR Health Care Services
